Study tests which common antibiotic better shields vulnerable transplant patients
NCT ID NCT03850379
Summary
This study aimed to find out which of two commonly used antibiotics, ciprofloxacin or levofloxacin, is better at preventing serious bloodstream infections in patients recovering from a stem cell transplant. It involved 308 adults with blood cancers who received a transplant. Researchers compared the rate of infections in the first 60 days after transplant to see which medication provided more effective protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford
Detroit, Michigan, 48202, United States
Conditions
Explore the condition pages connected to this study.